Peripheral surrogates of tumor burden to guide therapeutic strategies for HPV-associated malignancies
“We discuss existing clinical data on these surrogates of tumor burden and their potential in evaluating efficacy of immunotherapy in ...
Tag: malignancies
CDK9 Inhibitors: A promising combination partner in treating hematological malignancies
“ CDK9 inhibitors could play a role in future treatments of hematological diseases and could be a great ally when ...
Oncotarget | The role of pyrethroid derivatives in autophagy and apoptosis crosstalk signaling and potential risk for malignancies
“Pyrethroid derivatives and related products exposure have revealed to intensify various ailments and adverse health consequence in the different age ...
NCCN Annual Congress on Hematologic Malignancies™ returns to in-person October 14–15, 2022 in New York City
PLYMOUTH MEETING, PA — For the first time in three years, the National Comprehensive Cancer Network® (NCCN®) is hosting its ...
What caused the blood malignancies linked to gene therapy for sickle cell disease?
Gene therapy trials for sickle cell disease have been showing great promise, even offering hope of a cure. But in ...
New clinical trials from University Hospitals Seidman Cancer Center to begin with human protein following successful on-site approach to producing and using anti-CD19 CAR T cells against B-cell malignancies
CLEVELAND- Newly designed chimeric antigen receptor (CAR) T-cells targeting the CD19 antigen are effective in treating adults and children with ...
-
Null results research now published by major behavioral medicine journal
-
How drugs can target the thick “scar tissue” of pancreatic cancer
-
‘Shocking’ discovery: Electricity from electric eels may transfer genetic material to nearby animals
-
Study identifies key ingredient for affordable fuel cell catalysts
-
Meteorites likely source of nitrogen for early Earth
-
Pivotal moment for humanity as tipping point threats and opportunities accelerate